GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins May 21, 2025
Displaying entries 34801 - 34850 of 41762 in total
PDB ID UniProt ID ▲ Title Descriptor
6Z3J Q6NW40 Repulsive Guidance Molecule B (RGMB) in complex with Growth Differentiation Factor 5 (GDF5) (crystal form 1)
6Z3M Q6NW40 Repulsive Guidance Molecule B (RGMB) in complex with Growth Differentiation Factor 5 (GDF5) and Neogenin 1 (NEO1).
4BQ6 Q6NW40 Crystal structure of the RGMB-NEO1 complex form 1
4BQ8 Q6NW40 Crystal structure of the RGMB-NEO1 complex form 3
4UI2 Q6NW40 Crystal structure of the ternary RGMB-BMP2-NEO1 complex NEOGENIN, BONE MORPHOGENETIC PROTEIN 2, BMP2, REPULSIVE GUIDANCE MOLECULE C, RGMC, HEMOJUVELIN
5WZY Q6NYR1 Crystal structure of the P2X4 receptor from zebrafish in the presence of CTP at 2.8 Angstroms
3H9V Q6NYR1 Crystal structure of the ATP-gated P2X4 ion channel in the closed, apo state at 3.1 Angstroms
3I5D Q6NYR1 Crystal structure of the ATP-gated P2X4 ion channel in the closed, apo state at 3.5 Angstroms (R3)
4DW0 Q6NYR1 Crystal structure of the ATP-gated P2X4 ion channel in the closed, apo state at 2.9 Angstroms
4DW1 Q6NYR1 Crystal structure of the ATP-gated P2X4 ion channel in the ATP-bound, open state at 2.8 Angstroms
8JV5 Q6NYR1 Cryo-EM structure of the zebrafish P2X4 receptor in complex with BX430
8JV6 Q6NYR1 Cryo-EM structure of the zebrafish P2X4 receptor in complex with BAY-1797
6EA4 Q6P179 ERAP2 bound to Aryl Sulfonamide Uncompetitive Inhibitor
3SE6 Q6P179 Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2
4E36 Q6P179 Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 variant N392K
4JBS Q6P179 Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 in complex with PHOSPHINIC PSEUDOTRIPEPTIDE inhibitor.
5AB0 Q6P179 Crystal structure of aminopeptidase ERAP2 with ligand
5AB2 Q6P179 Crystal structure of aminopeptidase ERAP2 with ligand
5CU5 Q6P179 Crystal structure of ERAP2 without catalytic Zn(II) atom
5J6S Q6P179 Crystal structure of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) in complex with a hydroxamic derivative ligand
5K1V Q6P179 Crystal structure of Endoplasmic Reticulum aminopeptidase 2 (ERAP2) in complex with a diaminobenzoic acid derivative ligand.
7P7P Q6P179 Crystal structure of ERAP2 aminopeptidase in complex with phosphinic pseudotripeptide((1R)-1-Amino-3-phenylpropyl){(2S)-3-[((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino]-2-{[3-(2-hydroxyphenyl)-isoxazol-5-yl]methyl}-3-oxopropyl}phosphinic acid
7PFS Q6P179 Crystal structure of ERAP2 aminopeptidase in complex with phosphinic pseudotripeptide ((1R)-1-Amino-3-phenylpropyl){2-([1,1:3,1-terphenyl]-5-ylmethyl)-3-[((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)-amino]-3-oxopropyl}phosphinic acid
7NSK Q6P179 Endoplasmic reticulum aminopeptidase 2 complexed with a hydroxamic ligand
7NUP Q6P179 Endoplasmic reticulum aminopeptidase 2 complexed with a mixed hydroxamic and sulfonyl ligand
5WKI Q6P4G7 Crystal structure of PG90 TCR-CD1b-PG complex
9B8O Q6P503 Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3, Vo
9BRD Q6P503 Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3
7RTW Q6P5F7 Cryo-EM structure of a TTYH3 cis-dimer
6WM3 Q6P5S7 Human V-ATPase in state 2 with SidK and ADP
6WLW Q6P5S7 The Vo region of human V-ATPase in state 1 (focused refinement)
7U4T Q6P5S7 Human V-ATPase in state 2 with SidK and mEAK-7
6WM2 Q6P5S7 Human V-ATPase in state 1 with SidK and ADP
6WM4 Q6P5S7 Human V-ATPase in state 3 with SidK and ADP
7UNF Q6P5S7 CryoEM structure of a mEAK7 bound human V-ATPase complex
2NXY Q6P5S8 HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b
2NXZ Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b
2NY0 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b
2NY1 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b
2NY2 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b
2NY3 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b
2NY4 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b
2NY5 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b
2NY6 Q6P5S8 HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b
6AL5 Q6P5S8 COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB
6AL5 Q6P5S8 COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB
6V8Z Q6P5S8 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure
6V8Z Q6P5S8 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure
6TUZ Q6P988 Theophylline-Notum complex
6TV4 Q6P988 CFF-Notum complex

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.2.1

Last updated: April 7, 2025